The Latest Breaking News from Obesity

The drug semaglutide, commonly known by the brand names Ozempic or Wegovy, was originally developed to help people with type 2 diabetes manage their blood sugar levels.

Two-thirds of the UK population are either overweight or obese – a crisis that costs billions each year in healthcare and lost productivity. Yet, in a 2021 review of nearly 700 obesity-related policies in England, researchers at the University of Cambridge found no evidence they had successfully reduced obesity. A…

Health experts are more worried about diabetes than before because the onset of the disease has migrated to younger individuals these days. This silent epidemic is bringing quality life to a halt for many individuals at a young age. What is more concerning is that though a lot is being…

Diabetes and obesity are lifestyle conditions that cause significant metabolic disturbances. If not managed, they can be precursors to serious ailments including, cardiovascular, kidney liver diseases, hormonal disturbances and others. While diabetes has always been identified as a chronic metabolic disorder, obesity is now gradually being recognised as a diseased…

The world’s largest food and beverage companies are selling less healthy products in low-income countries compared to those in wealthier nations – contributing to the global obesity crisis as packaged foods become more prevalent worldwide, a report has warned.

“Aren’t they a little young for that?”

Women with polycystic ovary syndrome, also known as PCOS and obesity are more likely to have smaller babies in terms of birth weight, length, and head NTNU. Read further on Dynamite News:

Health and children’s groups urge UK ministers to impose levies on products containing too much salt or sugar

Globally, one in eight people are living with obesity. This is an issue because excess fat increases the risk of type 2 diabetes, heart disease and certain cancers.

Robert F. Kennedy Jr. plans FDA reform targeting ultra-processed foods to address health concerns and potential corruption allegations.

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted Wednesday strong third-quarter earnings despite being held back by production constraints.